GENEWITY Trademark

Trademark Overview


On Monday, May 13, 2024, a trademark application was filed for GENEWITY with the United States Patent and Trademark Office. The USPTO has given the GENEWITY trademark a serial number of 79398550. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, July 22, 2025. This trademark is owned by GWYIP B.V.. The GENEWITY trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical drugs being pharmaceutical preparations for the treatment of immune system related diseases and disorders; tissue-regenerative pharmaceutical preparations for the treatment of immune system related diseases and disorders; stem cells for veterinary purposes; pharmaceutical preparations containing stem cells for the treatment of immune system related diseases and disorders; stem cells for medical purposes; surgical implants grown from stem cells

Development of pharmaceutical preparations and medicines; research and development in the pharmaceutical and biotechnology fields; biotechnology research; gene-therapy research; medical research in the field of gene therapy
genewity

General Information


Serial Number79398550
Word MarkGENEWITY
Filing DateMonday, May 13, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, July 22, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 12, 2025

Trademark Statements


Description of MarkThe mark consists of a stylized design of a DNA helix in green and the wording "GENEWITY" in green font.
Goods and ServicesPharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical drugs being pharmaceutical preparations for the treatment of immune system related diseases and disorders; tissue-regenerative pharmaceutical preparations for the treatment of immune system related diseases and disorders; stem cells for veterinary purposes; pharmaceutical preparations containing stem cells for the treatment of immune system related diseases and disorders; stem cells for medical purposes; surgical implants grown from stem cells
Indication of Colors claimedThe color(s) green is/are claimed as a feature of the mark.
Goods and ServicesDevelopment of pharmaceutical preparations and medicines; research and development in the pharmaceutical and biotechnology fields; biotechnology research; gene-therapy research; medical research in the field of gene therapy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 27, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 27, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGWYIP B.V.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNL

Trademark Events


Event DateEvent Description
Thursday, June 27, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, June 28, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 28, 2024APPLICATION FILING RECEIPT MAILED
Monday, November 25, 2024NON-FINAL ACTION WRITTEN
Monday, November 25, 2024ASSIGNED TO EXAMINER
Tuesday, November 26, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, December 9, 2024REFUSAL PROCESSED BY MPU
Tuesday, December 10, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sunday, December 29, 2024REFUSAL PROCESSED BY IB
Wednesday, July 2, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 6, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 9, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 9, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 9, 2025TEAS/EMAIL CORRESPONDENCE ENTERED